The COVID-19 pandemic has had a profound effect across society, but it has been especially devastating for people with substance use disorder. New research from Oregon Health & Science University concludes that health systems nationwide could benefit from a better understanding of people who struggle with the basics.
Pandemic-related anxiety, boredom, and irregular routines were cited as major drivers of increased nicotine and tobacco use during the initial COVID-19 "lockdown," according to research just released by Columbia University Mailman School of Public Health. The study highlights ways that public health interventions and policies can better support quit attempts and harm reduction, both during the COVID-19 pandemic and beyond.
Social distancing guidelines have reduced the spread of COVID-19, but lockdowns and isolation also have created or aggravated other well-being concerns, reports new research. Mayo Clinic investigators found a significant increase in loneliness and a decrease in feelings of friendship during the pandemic. The study, published Feb. 20 in the journal Social Science & Medicine, also showed disproportionate negative effects among women and those with poorer health.
A series of weekend workshops that integrate strategies for both reducing risky alcohol use and preventing sexually transmitted infections (STIs) led to an increase in safe sex and decrease in drinking among young Black women, according to a new study published in the American Journal of Preventive Medicine.
Social work professor Douglas C. Smith of the University of Illinois Urbana-Champaign developed a mobile app called Harbor that assists young adults in talking with peers who are engaging in risky drug or alcohol use.
"The experiment proved that the filter is a crucial element in reducing the harm of smoking so therefore, new filters need to be developed to reduce toxicity," explains Prof. Robert Marks, head of the BGU Avram and Stella Goldstein-Goren Department of Biotechnology Engineering. Prof. Robert Marks is a leading expert in the study of genetically engineered bacteria. His work focuses on finding the specific mechanisms of toxins in a variety of materials and their impact on the environment.
New research shows that people diagnosed with a genetic condition, called alpha-1 antitrypsin deficiency (AATD), are far more likely to stop smoking and therefore prevent the development of lung disease.
CLEVELAND, Ohio (March 3, 2021)--The loss of estrogen after menopause is associated with rapid bone loss. A new study compared the bone health outcomes in women with primary ovarian insufficiency (POI) and early menopause with women who experienced menopause at the standard age to confirm the association between POI and osteoporosis. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
The drug buprenorphine is an effective treatment for opioid use disorder, but many who misuse opioids also take benzodiazepines -- drugs that treat anxiety and similar conditions. Many treatment centers hesitate to treat patients addicted to opioids who also take benzodiazepines. Researchers at Washington University School of Medicine in St. Louis studied overdose risk in people taking buprenorphine and found that the drug lowered risk, even in people taking benzodiazepines.
Researchers in this randomized clinical trial examined the effectiveness of incentives offered for laboratory-confirmed abstinence from alcohol among American Indian and Alaska Native adults diagnosed with alcohol dependence.